The 38th Congress of the European Society of Surgical Oncology

The 38th Congress of the European Society of Surgical Oncology will take place from 10-12 October 2018 in Budapest, Hungary.

Focusing on bridging the disparity between minimum standards of care across Europe, the overarching theme of the Congress is ‘Better outcome with Innovative Surgery’.

Featuring a comprehensive three day scientific programme of excellence devised by leading scientific and surgical experts, the event ensures exceptional quality and offers extraordinary educational and networking opportunities.

The Congress will focus on the leading role of surgical oncology in the management of solid tumours, in a multidisciplinary setting and as part of the multimodal approach.

ESSO 38 will offer a scientific environment and platform for the oncology and surgical oncology community, including general surgeons, surgical oncologists of different specialties, students, surgeons in training, residents, specialist nurses and all healthcare workers involved in managing cancer patients.

Our aim is to provide delegates with unique educational opportunities, workshops, debates on controversial issues and a platform to interact and establish new collaborations.

The latest developments and key aspects in surgical oncology will be discussed through an array of interactive sessions to highlight the significance of a multidisciplinary approach in the management of solid tumours and raise the quality level of surgical oncology care in Europe.

State-of-the-art advances in surgical research, patient management and practice, standards in surgical oncology, key guidelines, practice changing developments will all be showcased in Plenary Lectures, Meet the Expert Sessions, Debates, Scientific Symposia and Poster Sessions in well-defined tracks.

We look forward to welcoming you to the stunning city of Budapest for what promises to be another informative, stimulating and rewarding surgical oncology meeting with opportunities for sharing expertise, building relations between clinicians and researchers, collaboration and links amongst cancer specialists from Europe and beyond.